10.46243/jst.2025.v10.i6.pp62-82 registered
Use of human hepatocytes from the second generation of the upcyte® brand in investigations of CYP inhibition and induction
Resolves to https://www.jst.org.in/index.php/pub/article/view/1379
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2025.v10.i6.pp62-82
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 02d6723331fd0930…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Use of human hepatocytes from the second generation of the upcyte® brand in investigations of CYP inhibition and induction (PrincipalTitle · en)
Published 2025-06-24
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 10 · issue 06 · pages 62–82
Agents
- Dr. B. ARUNA (author)
- DR.M.SPURTHIMITHRA (author)
- DR C.RENUKATEJASWINI (author)
- DR M SRIRAMACHANDRA (author)
- DR S.RAJESHRAJA (author)
- DR S.RAJESHRAJA (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2025.v10.i6.pp62-82
Abstract · en
Histologic features shared by primary human hepatocytes are maintained by proliferating hepatocytes from the human upcyte® line. The use of four donors' second-generation upcyte® hepatocytes in inhibition and induction tests with a variety of reference inhibitors and inducers was thoroughly evaluated. Reproducible inhibition of CYP1A2, CYP2B6, CYP2C9, and CYP3A4 occurred at concentrations ranging from very low to very high, and the IC50 values computed for each chemical accurately designated them as powerful inhibitors.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2025.v10.i6.pp62-82 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Use of human hepatocytes from the second generation of the upcyte® brand in investigations of CYP inhibition and induction (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Dr. B. ARUNA author: DR.M.SPURTHIMITHRA author: DR C.RENUKATEJASWINI author: DR M SRIRAMACHANDRA author: DR S.RAJESHRAJA author: DR S.RAJESHRAJA publisher: Longman Publishers published: 2025-06-24 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 10 · no. 06 · pp. 62–82 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-08-27 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 30 references; 26 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 1 | ref1 Antherieu S, Chesne C, Li R, Camus S, Lahoz A, Picazo L, et al. (2010). Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Meta… | 10.1124/dmd.109.030197 | not held here |
| 2 | ref2 Burkard A, Dahn C, Heinz S, Zutavern A, Sonntag-Buck V, Maltman D, et al. (2012). Generation of proliferating human hepatocytes using Upcyte(R) technology: characterisation and ap… | 10.3109/00498254.2012.675093 | not held here |
| 3 | ref3 Chu V, Einolf HJ, Evers R, Kumar G, Moore D, Ripp S, et al. (2009). In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pha… | 10.1124/dmd.109.027029 | not held here |
| 4 | ref4 Di L, Keefer C, Scott DO, Strelevitz TJ, Chang G, Bi YA, et al. (2012). Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocyt… | 10.1016/j.ejmech.2012.06.043 | not held here |
| 5 | ref5 EMA (2012). Guideline on the investigation of drug interactions. 21 June 2012, CPMP/ EWP/560/95/Rev. 1 Corr. 2, Committee for Human Medicinal Products (CHMP) http:// www.ema.europ… | 10.2165/00128415-201214100-00010 | not held here |
| 6 | ref6 Emoto C, Murase S, Sawada Y, Iwasaki K (2005). B. ARUNA, M.SPURTHIMITHRA, C. RENUKATEJASWINI, M SRIRAMACHANDRA, S.RAJESHRAJA, R.JONA METHUSULA: Use of human hepatocytes from the s… | 10.2133/dmpk.20.351 | not held here |
| 7 | ref7 Fahmi OA, Boldt S, Kish M, Obach RS, Tremaine LM (2008). Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach us… | 10.1124/dmd.108.021907 | not held here |
| 8 | ref8 Faucette SR, Wang H, Hamilton GA, Jolley SL, Gilbert D, Lindley C, et al. (2004). Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos 32:… | 10.1124/dmd.32.3.348 | not held here |
| 9 | ref9 Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski CJ, LeCluyse EL, et al. (2007). Relative activation of human pregnane X receptor versus constitutive androstane receptor def… | 10.1124/jpet.106.112136 | not held here |
| 11 | ref11 Georgoff I, Secott T, Isom HC (1984). Effect of simian virus 40 infection on albumin production by hepatocytes cultured in chemically defined medium and plated on collagen and non… | 10.1016/s0021-9258(17)42742-6 | not held here |
| 12 | ref12 Hariparsad N, Carr BA, Evers R, Chu X (2008). Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos 36:… | 10.1124/dmd.108.020677 | not held here |
| 13 | ref13 Hewitt NJ, Lecluyse EL, Ferguson SS (2007). Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 37: … | 10.1080/00498250701534893 | not held here |
| 14 | ref14 Kanebratt KP, Andersson TB (2008). HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans. Drug Metab Dispos 36: 137–145 | 10.1124/dmd.107.017418 | not held here |
| 15 | ref15 LeCluyse EL (2001). Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13: 343–368 | 10.1016/s0928-0987(01)00135-x | not held here |
| 16 | ref16 Levy G, Bomze D, Heinz S, Ramachandran SD, Noerenberg A, Shibolet O, et al. (2015). Genetic induction of metabolically functional, polarized cultures of proliferating human hepato… | 10.1038/nbt.3377 | not held here |
| 17 | ref17 Mao J, Mohutsky MA, Harrelson JP, Wrighton SA, Hall SD (2012). Predictions of cytochrome P450-mediated drug-drug interactions using cryopreserved human hepatocytes: comparison of … | 10.1124/dmd.111.043158 | not held here |
| 20 | ref20 No€renberg A, Heinz S, Scheller K, Hewitt NJ, Braspenning J, Ott M (2013). Optimization of upcyte(R) human hepatocytes for the in vitro micronucleus assay. Mutat Res 758: 69–79 | 10.1016/j.mrgentox.2013.09.008 | not held here |
| 21 | ref21 Raucy JL (2003). Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31: 533– | 10.1124/dmd.31.5.533 | not held here |
| 22 | ref22 Richter T, Murdter TE, Heinkele G, Pleiss J, Tatzel S, Schwab M, et al. (2004). Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine. J Pharmacol Exp T… | 10.1124/jpet.103.056127 | not held here |
| 23 | ref23 Ripp SL, Mills JB, Fahmi OA, Trevena KA, Liras JL, Maurer TS, et al. (2006). Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caus… | 10.1124/dmd.106.010132 | not held here |
| 24 | ref24 Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, et al. (2003). Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab Di… | 10.1124/dmd.31.4.439 | not held here |
| 25 | ref25 Scheller K, Dally I, Hartmann N, Munst B, Braspenning J, Walles H (2013). Upcyte(R) B. ARUNA, M.SPURTHIMITHRA, C. RENUKATEJASWINI, M SRIRAMACHANDRA, S.RAJESHRAJA, R.JONA METHUSULA… | 10.1089/ten.tec.2011.0723 | not held here |
| 26 | ref26 Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O (2004). Selective inhibition of CYP2B6- catalyzed bupropion hydroxylation in human liver microsomes in vi… | 10.1124/dmd.32.6.626 | not held here |
| 27 | ref27 Wang H, Faucette S, Moore R, Sueyoshi T, Negishi M, LeCluyse E (2004). Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Che… | 10.1074/jbc.m400580200 | not held here |
| 28 | ref28 Westerink WM, Schoonen WG (2007). Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:… | 10.1016/j.tiv.2007.05.014 | not held here |
| 29 | ref29 Youdim KA, Tyman CA, Jones BC, Hyland R (2007). Induction of cytochrome P450: assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cock… | 10.1124/dmd.106.012864 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 160 fields set · sha256 8f25134e1736… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 11 Sep 2026, 05:24 | Address updated from https://jst.org.in/index.php/pub/article/view/1379/1024 to https://www.jst.org.in/index.php/pub/article/view/1379 | ● accepted by Crossref | a28bf55a76fc… |
| 13 Sep 2026, 01:41 | Read back: the DOI resolves to the new address | ● confirmed | de08374bb2c4… |
| 15 Oct 2026, 15:29 | Metadata completed abstract (77 words) · licence | ● accepted by Crossref | d0139bcb3b1f… |
| 15 Oct 2026, 16:20 | Read back: Crossref's record shows it | ● confirmed | 09470d507956… |
4 entries · the last fingerprint 09470d507956d61637c082cd20e46cf95647c2226078fd986a0ec6ef6d4d8a09 · the history as JSON, each entry with the fingerprint before it, to check them yourself.



